Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

A key advisory group vows to base decisions on evidence, boost confidence in vaccines and protect health. Experts fear the opposite is happening.

The US Food and Drug Administration’s top vaccine official overrode agency experts in May to recommend against the broad use ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...